5 studies found for:    S0931
Show Display Options
Rank Status Study
1 Recruiting S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Condition: Kidney Cancer
Interventions: Drug: everolimus;   Other: placebo
2 Completed Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors
Conditions: Brain and Central Nervous System Tumors;   Neuroblastoma
Intervention: Drug: temozolomide
3 Active, not recruiting Monoclonal Antibody Ch14.18, Sargramostim, Aldesleukin, and Isotretinoin After Autologous Stem Cell Transplant in Treating Patients With Neuroblastoma
Conditions: Disseminated Neuroblastoma;   Localized Resectable Neuroblastoma;   Localized Unresectable Neuroblastoma;   Regional Neuroblastoma;   Stage 4S Neuroblastoma
Interventions: Biological: aldesleukin;   Other: diagnostic laboratory biomarker analysis;   Biological: sargramostim;   Biological: monoclonal antibody Ch14.18;   Drug: isotretinoin
4 Completed
Has Results
RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial
Condition: Atrial Fibrillation
Interventions: Drug: dabigatran dose 1;   Drug: dabigatran dose 2
5 Completed
Has Results
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: warfarin;   Drug: Dabigatran dose 1;   Drug: Dabigatran dose 2

Indicates status has not been verified in more than two years